The Drug Enforcement Administration has reversed its decision to the scheduling proposal that would have placed five tryptamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act.

Activists staged a demonstration outside of the Drug Enforcement Administration headquarters in Virginia, demanding that the agency allow terminally ill patients to access psilocybin therapy. The Protest was meant to call attention to DEA’s obstruction of Right to Try statutes at the federal and state level that patients and advocates say should facilitate legal use of psychedelics.